D70.1

Billable
ChapterD50–D89
Ranksubcategory
Official Description

Agranulocytosis secondary to cancer chemotherapy

Metadata & Insights
  • •2026 ICD-10-CM Edition - Effective October 1, 2025.
  • •Billable/specific code (valid for reimbursement).
  • •Chapter 3: Diseases of the Blood and Blood-Forming Organs (D50-D89).

Instructional Notes

Code Also
  • underlying neoplasm
Use Additional Code
  • code for adverse effect, if applicable, to identify drug (T45.1X5)
General instructions are available for the parent sections:
View CH3 NotesView D70 Notes

Clinical Hierarchy

CH3Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
D70-D77Other disorders of blood and blood-forming organs (D70-D77)
D70Neutropenia
D70.1Agranulocytosis secondary to cancer chemotherapy

Applicable Ancestor Context

The following parent sections contain instructions or notes that apply to D70.1:

categoryD70
Neutropenia
View context instructions
chapterCH3
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
View context instructions

Alphabetic Index Mentions

These are Diagnosis Index lookup paths that route to D70.1. Use them as entry terms for search, then confirm final coding instructions in the Tabular List and notes above.

8 raw paths
Agranulocytosis (chronic) (cyclical) (genetic) (infantile) (periodic) (pernicious)3 unique routes
cytoreductive cancer chemotherapy sequela→D70.1
drug-induced
due to cytoreductive cancer chemotherapy→D70.1
secondary
drug-induced
due to cytoreductive cancer chemotherapy→D70.1
Leukopenia2 unique routes
chemotherapy (cancer) induced→D70.1
drug induced NEC
due to cytoreductive cancer chemotherapy→D70.1
Neutropenia, neutropenic (chronic) (genetic) (idiopathic) (immune) (infantile) (malignant) (pernicious) (splenic)3 unique routes
cytoreductive cancer chemotherapy sequela→D70.1
drug-induced
due to cytoreductive cancer chemotherapy→D70.1
secondary (cyclic) (periodic) (splenic)
drug-induced
due to cytoreductive cancer chemotherapy→D70.1

MS-DRG Classification

2026 v43.1

This code is grouped within the following Diagnosis Related Group(s) for clinical reimbursement:

DRG 808
Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with MCC
DRG 809
Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with CC
DRG 810
Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders without CC/MCC

Cross Reference

Find Procedures (ICD-10-PCS)

Find surgical and procedural codes related to Agranulocytosis secondary to cancer chemotherapy.

Search PCS Codes